Clinical Trials Browser

Expanded_access × ponatinib × Other hematologic neoplasm × Clear all

NCT01592136 2018-02-06

Expanded Access Program of Ponatinib

Approved for marketing

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01549548 2013-03-15

Compassionate Use Ponatinib

No longer available

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive